---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-001473"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:48:49.991360+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lipella receives Nasdaq delisting notice; equity $1.7M vs $2.5M minimum

## Summary
- Nasdaq notified Lipella on Aug 21, 2024 of non-compliance with $2.5M minimum stockholders' equity requirement.
- Company reported stockholders' equity of $1,703,798 in Q2 10-Q, below the $2.5M threshold.
- Company must submit compliance plan by Oct 7, 2024; intends to do so.
- If plan accepted, Nasdaq may grant up to 180-day extension from Aug 21, 2024.
- Failure to regain compliance could result in delisting of LIPO common stock.

## SEC filing metadata
- accession: 0001753926-24-001473
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001473/0001753926-24-001473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624001473/g084405_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-001473
- JSON: https://secwatch.observer/filing/0001753926-24-001473.json
- Plain text: https://secwatch.observer/filing/0001753926-24-001473.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.